Amicus Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
FOLD on Nasdaq
Industry
Pharmaceutical Preparations
Location
47 Hulfish Street, Princeton, NJ

Insiders trading volume in the past year

Amicus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley L. Campbell President and CEO, Director $11.1M -$1.56M -12.4% Nov 6, 2024
John F. Crowley Executive Chairman, Director $8.52M -$3.32M -28% Mar 1, 2024
Jeff Castelli Chief Development Officer $5.15M -$506K -8.96% Jan 9, 2024
Ellen Rosenberg Chief Legal Officer $4.97M -$1.31M -20.8% Feb 6, 2024
Daphne Quimi Chief Financial Officer $4.93M Jan 17, 2023
David Michael Clark Chief People Officer $3.55M -$204K -5.42% Feb 15, 2024
Simon N.R. Harford Chief Financial Officer $1.84M Aug 21, 2024
Burke W. Whitman Director $982K Jun 6, 2024
Michael Raab Director $954K Jun 6, 2024
Glenn Sblendorio Director $954K Jun 6, 2024
Lynn Dorsey Bleil Director $935K Jun 6, 2024
Samantha Prout Chief Accounting Officer $788K -$557K -41.4% Apr 15, 2024
Margaret G. Mcglynn Director $711K -$200K -22% Jun 6, 2024
Craig A. Wheeler Director $642K Jun 6, 2024
Eiry Roberts Director $559K Jun 6, 2024
Michael Aaron Kelly Director $521K Jun 6, 2024
Robert Essner Director $385K Jun 10, 2021

Recent Insider Transactions by Companies or Individuals for Amicus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.